(Q43686218)

25 November 2017

Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions (English)

1 reference

25 November 2017

1 reference

Hattenbach LO

1

1 reference

25 November 2017

Klais C

series ordinal

2

1 reference

25 November 2017

Koch FH

series ordinal

3

1 reference

25 November 2017

Gümbel HO

series ordinal

4

1 reference

25 November 2017

1 August 2001

1 reference

25 November 2017

1 reference

25 November 2017

108

1 reference

25 November 2017

8

1 reference

25 November 2017

1485-1492

1 reference

Variations in the clinical course of submacular hemorrhage

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Factors prognostic of visual outcome in patients with subretinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Natural history of macular subretinal hemorrhage in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Senile disciform macular degeneration complicated by massive hemorrhagic retinal detachment and angle closure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Experimental subretinal hemorrhage in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Surgical management of submacular hemorrhage. A series of 47 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Submacular hemorrhage removal

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Tissue Plasminogen Activator Treatment of Experimental Subretinal Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Fibrin directs early retinal damage after experimental subretinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Fibrinolysis of experimental subretinal haemorrhage without removal using tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Tissue plasminogen activator for postvitrectomy fibrin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Intravitreal clearance of tissue plasminogen activator in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Tissue plasminogen activator treatment of experimental subretinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900648-0

7 January 2021

10.1016/S0161-6420(01)00648-0

Identifiers

DOI

1 reference

25 November 2017

1 reference